+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

ratiopharm GmbH - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 18 Pages
  • September 2023
  • GlobalData
  • ID: 1368074
1h Free Analyst Time

Quick Summary:

In the ever-changing pharmaceutical sector, understanding your market stakeholders is crucial to maintaining your competitive edge. The ratiopharm GmbH SWOT Analysis report is an indispensable tool tailored to provide that crucial advantage. It presents an in-depth, well-researched view of ratiopharm, a prominent player in the pharmaceutical industry, and a subsidiary of the reputed Teva Pharmaceutical Industries.

The comprehensive report combines a fine detail of the company's current standing and historical events, with a pertinent SWOT analysis that fully exposes the firm's strengths, weaknesses, opportunities, and threats. This combination of data enables effective formulation of strategies by offering a prism to view potential partners, customers, rivals, and business operations. With this meticulous perspective, you can address and exploit the company's structure, strategy, and business operations to steer your enterprise effectively. Identifying potential customers, suppliers and investment entities has never been easier. The company's top-tier executives' profiles alongside key operational heads bring unique insights into its decision-making process as well. Allow this profile to aid your academic or business research and take your strategic planning to the next level. Don't let vital data remain unutilized. Elevate your business acumen with the ratiopharm GmbH SWOT Analysis report.

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

ratiopharm GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.


ratiopharm GmbH (ratiopharm), a subsidiary of Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that develops, manufactures and sells generic medicines and biosimilars. The company’s product portfolio comprises original products, generics, biotechnology products and over-the counter (OTC) products. It offers products in various forms such as creams, suppositories, tablets, ampoules, ointment, and liquids. ratiopharm develops medicines for cancer, allergies, anemia, colds, osteoarthritis, anxiety disorders, erectile dysfunction, and urinary inconsistency among others. ratiopharm is headquartered in Ulm, Germany.

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • ratiopharm GmbH - Key Facts
  • ratiopharm GmbH - Key Employees
  • ratiopharm GmbH - Major Products and Services
  • ratiopharm GmbH - History
  • ratiopharm GmbH - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • ratiopharm GmbH - Business Description
  • ratiopharm GmbH - SWOT Analysis
  • SWOT Analysis - Overview
  • ratiopharm GmbH - Strengths
  • ratiopharm GmbH - Weaknesses
  • ratiopharm GmbH - Opportunities
  • ratiopharm GmbH - Threats
  • ratiopharm GmbH - Key Competitors
Section 3 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • ratiopharm GmbH, Key Facts
  • ratiopharm GmbH, Key Employees
  • ratiopharm GmbH, Major Products and Services
  • ratiopharm GmbH, History
  • ratiopharm GmbH, Subsidiaries
  • ratiopharm GmbH, Key Competitors



Companies Mentioned

A selection of companies mentioned in this report includes:

  • Reaction Biology Europe GmbH
  • Pharmacelsus GmbH
  • Mylan Inc
  • Stada Arzneimittel AG
  • Sanofi
  • Merck KGaA
  • KSK Pharma AG
  • Aspen Germany Gmbh
  • Anoxymer GmbH
  • Evotec SE
  • Bausch Health Companies Inc
  • Corden BioChem GmbH
  • Stada Arzneimittel AG
  • Sanofi
  • Reaction Biology Europe GmbH
  • Pharmacelsus GmbH
  • Mylan Inc
  • Merck KGaA
  • KSK Pharma AG
  • Evotec SE
  • Corden BioChem GmbH
  • Bausch Health Companies Inc
  • Aspen Germany Gmbh
  • Anoxymer GmbH